Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOther Accumulated ExpensesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTreasury SharesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Argan (AGX) Accounts Payables (2016 - 2026)

Argan (AGX) has disclosed Accounts Payables for 16 consecutive years, with $107.5 million as the latest value for Q1 2026.

  • Quarterly Accounts Payables rose 10.53% to $107.5 million in Q1 2026 from the year-ago period, while the trailing twelve-month figure was $107.5 million through Jan 2026, up 10.53% year-over-year, with the annual reading at $107.5 million for FY2026, 10.53% up from the prior year.
  • Accounts Payables hit $107.5 million in Q1 2026 for Argan, up from $100.8 million in the prior quarter.
  • In the past five years, Accounts Payables ranged from a high of $107.5 million in Q1 2026 to a low of $31.5 million in Q3 2023.
  • Historically, Accounts Payables has averaged $64.0 million across 5 years, with a median of $56.4 million in 2023.
  • Biggest YoY gain for Accounts Payables was 216.18% in 2024; the steepest drop was 29.96% in 2024.
  • Year by year, Accounts Payables stood at $45.3 million in 2022, then decreased by 23.72% to $34.5 million in 2023, then skyrocketed by 152.19% to $87.1 million in 2024, then grew by 15.75% to $100.8 million in 2025, then grew by 6.69% to $107.5 million in 2026.
  • Business Quant data shows Accounts Payables for AGX at $107.5 million in Q1 2026, $100.8 million in Q4 2025, and $96.0 million in Q3 2025.